Interventional Cardiology Devices Market Overview

The report is titled ‘Interventional Cardiology Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the interventional cardiology devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The interventional cardiology devices market is expected to grow at a significant rate in the near future.

The interventional cardiology devices market size was valued at US$ 12.9 Bn in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% from 2020 to 2028.

Interventional Cardiology Devices Market Definition

An interventional medical device can be perceived as a medical equipment which serves its utility by performing procedures that manage a broad range of therapeutic areas. These areas comprise endocardial cartography to handle problems of the heart, neurovascular equipment are developed to deal aneurysms, and biopsy devices are developed to engage with soft tissue.

Further, the interventional cardiology devices are developed to sustain the natural cadence of heartbeats. Interventional cardiology devices have lowered complexities for patients and ensure quick recovery.

Notably, the interventional cardiology devices market comprises a comprehensive extent of devices such as catheter, cardiovascular stents, cardiac monitoring devices, coil, conventional surgical tools, and imaging devices.

Interventional Cardiology Devices Market Dynamics

Nowadays, the treatment and therapeutic approach of the healthcare professionals have changed dramatically along with the advancements in the healthcare sector which has majorly boosted the demand of interventional cardiology devices across the global markets.

In addition to that, the Interventional cardiology devices have numerous benefits for the patients including depreciation of risks of scars, curtailed surgery time and complications as well as diminished pain. Owing to which, the global interventional cardiology devices market is projected to grow significantly in the forthcoming years.

However, the heavy cost of the surgical and interventional cardiology procedures are likely to hold back the growth of the global interventional cardiology devices market over the forecast period.

Interventional Cardiology Devices Market Segmentation

The global interventional cardiology devices market is segmented on the basis of product and region.

By Product

Angioplasty Balloons

Old/Normal Balloons

Drug-eluting Balloons

Cutting and Scoring Balloons

Angioplasty Stents

Drug-eluting Stents

Bare-metal Stents

Bioabsorbable Stents

Structural Heart Devices

Aortic Valve Therapy Devices

Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

Catheters

Angiography Catheters

Guiding Catheters

IVUS/OCT Catheters

Plaque Modification Devices

Atherectomy Devices

Thrombectomy Devices

Hemodynamic Flow Alteration Devices

Embolic Protection Devices

Chronic Total Occlusion Devices

Other Devices

Guidewires

Vascular Closure Devices

Introducer Sheaths

Hemostasis Valves

Balloon Inflation Devices

By Region

North America

Latin America

Europe

Africa

Middle East

Asia Pacific

Interventional Cardiology Devices Market Key Players

The key participating players of the global interventional cardiology devices market include Medtronic, Boston Scientific Corporation, Abbott, Edward Lifesciences Corporation, Cardinal Health, iVascular, Becton, Dickinson, and Company, B. Braun Melsungen, Terumo Corporation, Biosensors International Group, and BIOTRONIK SE & Co. KG, among others.

MMC Overview on Interventional Cardiology Devices Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.

A research report on the Interventional Cardiology Devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Interventional Cardiology Devices

Advantages of Interventional Cardiology Devices

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make informed decisions.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Interventional Cardiology Devices Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Interventional Cardiology Devices Market Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Interventional Cardiology Devices Market Snapshot

2.4.    Global Interventional Cardiology Devices Market Size And Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Interventional Cardiology Devices Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

3.    Interventional Cardiology Devices Assessment and Analysis

3.1.    Interventional Cardiology Devices Impact Analysis 

3.2.    Actions to encourage use of Interventional Cardiology Devices

3.3.    Interventional Cardiology Devices Promotional Strategy Recommendation

3.4.    Road Map Analysis

3.5.    GAP Analysis

3.6.    Potential Analysis

4.    Covid-19 Impact on Interventional Cardiology Devices Market

5.    Global Interventional Cardiology Devices Market, By Product

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Product

5.1.2.    BPS Analysis, By Product

5.2.    Market Revenue (US$Mn) and Forecast, By Product

5.2.1.    Angioplasty Balloons

5.2.1.1.    Old/Normal Balloons

5.2.1.2.    Drug-eluting Balloons

5.2.1.3.    Cutting and Scoring Balloons

5.2.2.    Angioplasty Stents

5.2.2.1.    Drug-eluting Stents

5.2.2.2.    Bare-metal Stents

5.2.2.3.    Bioabsorbable Stents

5.2.3.    Structural Heart Diseases

5.2.3.1.    Aortic Valve Therapy Devices

5.2.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

5.2.4.    Catheters

5.2.4.1.    Angiography Catheters

5.2.4.2.    Guiding Catheters

5.2.4.3.    IVUS/OCT Catheters

5.2.5.    Plaque Modification Devices

5.2.5.1.    Atherectomy Devices

5.2.5.2.    Thrombectomy Devices

5.2.6.    Hemodynamic Flow Alteration Devices

5.2.6.1.    Embolic Protection Devices

5.2.6.2.    Chronic Total Occlusion Devices

5.2.7.    Other Devices

5.2.7.1.    Guidewires

5.2.7.2.    Vascular Closure Devices

5.2.7.3.    Introducer Sheaths

5.2.7.4.    Hemostasis Valves

5.2.7.5.    Balloon Inflation Devices

5.3.    Global Interventional Cardiology Devices Market Attractiveness Index, By Product

6.    Global Interventional Cardiology Devices Market, By Region

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Region

6.1.2.    BPS Analysis, By Region

6.2.    Market Revenue (US$Mn) and Forecast, By Region

6.2.1.    North America

6.2.2.    Latin America

6.2.3.    Europe

6.2.4.    Asia Pacific

6.2.5.    Middle East 

6.2.6.    Africa

6.3.    Global Interventional Cardiology Devices Market Attractiveness Index, By Region

7.    North America Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market Revenue (US$Mn) and Forecast, By Country

7.2.1.    U.S. Interventional Cardiology Devices Market

7.2.2.    Canada Interventional Cardiology Devices Market

7.3.    North America Interventional Cardiology Devices Market, By Product

7.3.1.    Angioplasty Balloons

7.3.1.1.    Old/Normal Balloons

7.3.1.2.    Drug-eluting Balloons

7.3.1.3.    Cutting and Scoring Balloons

7.3.2.    Angioplasty Stents

7.3.2.1.    Drug-eluting Stents

7.3.2.2.    Bare-metal Stents

7.3.2.3.    Bioabsorbable Stents

7.3.3.    Structural Heart Diseases

7.3.3.1.    Aortic Valve Therapy Devices

7.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

7.3.4.    Catheters

7.3.4.1.    Angiography Catheters

7.3.4.2.    Guiding Catheters

7.3.4.3.    IVUS/OCT Catheters

7.3.5.    Plaque Modification Devices

7.3.5.1.    Atherectomy Devices

7.3.5.2.    Thrombectomy Devices

7.3.6.    Hemodynamic Flow Alteration Devices

7.3.6.1.    Embolic Protection Devices

7.3.6.2.    Chronic Total Occlusion Devices

7.3.7.    Other Devices

7.3.7.1.    Guidewires

7.3.7.2.    Vascular Closure Devices

7.3.7.3.    Introducer Sheaths

7.3.7.4.    Hemostasis Valves

7.3.7.5.    Balloon Inflation Devices

7.4.    North America Interventional Cardiology Devices Market Attractiveness Index

7.4.1.    By Country

7.4.2.    By Product

8.    Latin America Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) Forecast, By Country

8.2.1.    Brazil Interventional Cardiology Devices Market

8.2.2.    Mexico Interventional Cardiology Devices Market

8.2.3.    Rest Of Latin America Interventional Cardiology Devices Market

8.3.    Latin America Interventional Cardiology Devices Market, By Product

8.3.1.    Angioplasty Balloons

8.3.1.1.    Old/Normal Balloons

8.3.1.2.    Drug-eluting Balloons

8.3.1.3.    Cutting and Scoring Balloons

8.3.2.    Angioplasty Stents

8.3.2.1.    Drug-eluting Stents

8.3.2.2.    Bare-metal Stents

8.3.2.3.    Bioabsorbable Stents

8.3.3.    Structural Heart Diseases

8.3.3.1.    Aortic Valve Therapy Devices

8.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

8.3.4.    Catheters

8.3.4.1.    Angiography Catheters

8.3.4.2.    Guiding Catheters

8.3.4.3.    IVUS/OCT Catheters

8.3.5.    Plaque Modification Devices

8.3.5.1.    Atherectomy Devices

8.3.5.2.    Thrombectomy Devices

8.3.6.    Hemodynamic Flow Alteration Devices

8.3.6.1.    Embolic Protection Devices

8.3.6.2.    Chronic Total Occlusion Devices

8.3.7.    Other Devices

8.3.7.1.    Guidewires

8.3.7.2.    Vascular Closure Devices

8.3.7.3.    Introducer Sheaths

8.3.7.4.    Hemostasis Valves

8.3.7.5.    Balloon Inflation Devices

8.4.    Latin America Interventional Cardiology Devices Market Attractiveness Index

8.4.1.    By Country

8.4.2.    By Product

9.    Europe Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) Forecast, By Country

9.2.1.    U.K. Interventional Cardiology Devices Market

9.2.2.    Germany Interventional Cardiology Devices Market

9.2.3.    Italy Interventional Cardiology Devices Market

9.2.4.    France Interventional Cardiology Devices Market

9.2.5.    Spain Interventional Cardiology Devices Market

9.2.6.    Russia Interventional Cardiology Devices Market

9.2.7.    Rest Of Europe Interventional Cardiology Devices Market

9.3.    Europe Interventional Cardiology Devices Market, By Product

9.3.1.    Angioplasty Balloons

9.3.1.1.    Old/Normal Balloons

9.3.1.2.    Drug-eluting Balloons

9.3.1.3.    Cutting and Scoring Balloons

9.3.2.    Angioplasty Stents

9.3.2.1.    Drug-eluting Stents

9.3.2.2.    Bare-metal Stents

9.3.2.3.    Bioabsorbable Stents

9.3.3.    Structural Heart Diseases

9.3.3.1.    Aortic Valve Therapy Devices

9.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

9.3.4.    Catheters

9.3.4.1.    Angiography Catheters

9.3.4.2.    Guiding Catheters

9.3.4.3.    IVUS/OCT Catheters

9.3.5.    Plaque Modification Devices

9.3.5.1.    Atherectomy Devices

9.3.5.2.    Thrombectomy Devices

9.3.6.    Hemodynamic Flow Alteration Devices

9.3.6.1.    Embolic Protection Devices

9.3.6.2.    Chronic Total Occlusion Devices

9.3.7.    Other Devices

9.3.7.1.    Guidewires

9.3.7.2.    Vascular Closure Devices

9.3.7.3.    Introducer Sheaths

9.3.7.4.    Hemostasis Valves

9.3.7.5.    Balloon Inflation Devices

9.4.    Europe Interventional Cardiology Devices Market Attractiveness Index

9.4.1.    By Country

9.4.2.    By Product

10.    Asia Pacific Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    China Interventional Cardiology Devices Market

10.2.2.    India Interventional Cardiology Devices Market

10.2.3.    Japan Interventional Cardiology Devices Market

10.2.4.    Australia and New Zealand Interventional Cardiology Devices Market

10.2.5.    South Korea Interventional Cardiology Devices Market

10.2.6.    Rest of Asia Pacific Interventional Cardiology Devices Market

10.3.    Asia Pacific Interventional Cardiology Devices Market, By Product

10.3.1.    Angioplasty Balloons

10.3.1.1.    Old/Normal Balloons

10.3.1.2.    Drug-eluting Balloons

10.3.1.3.    Cutting and Scoring Balloons

10.3.2.    Angioplasty Stents

10.3.2.1.    Drug-eluting Stents

10.3.2.2.    Bare-metal Stents

10.3.2.3.    Bioabsorbable Stents

10.3.3.    Structural Heart Diseases

10.3.3.1.    Aortic Valve Therapy Devices

10.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

10.3.4.    Catheters

10.3.4.1.    Angiography Catheters

10.3.4.2.    Guiding Catheters

10.3.4.3.    IVUS/OCT Catheters

10.3.5.    Plaque Modification Devices

10.3.5.1.    Atherectomy Devices

10.3.5.2.    Thrombectomy Devices

10.3.6.    Hemodynamic Flow Alteration Devices

10.3.6.1.    Embolic Protection Devices

10.3.6.2.    Chronic Total Occlusion Devices

10.3.7.    Other Devices

10.3.7.1.    Guidewires

10.3.7.2.    Vascular Closure Devices

10.3.7.3.    Introducer Sheaths

10.3.7.4.    Hemostasis Valves

10.3.7.5.    Balloon Inflation Devices

10.4.    Asia Pacific Interventional Cardiology Devices Market Attractiveness Index

10.4.1.    By Country

10.4.2.    By Product

11.    Middle East Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    GCC Countries Interventional Cardiology Devices Market

11.2.2.    Israel Interventional Cardiology Devices Market

11.2.3.    Rest Of Middle East Interventional Cardiology Devices Market

11.3.    Middle East Interventional Cardiology Devices Market, By Product

11.3.1.    Angioplasty Balloons

11.3.1.1.    Old/Normal Balloons

11.3.1.2.    Drug-eluting Balloons

11.3.1.3.    Cutting and Scoring Balloons

11.3.2.    Angioplasty Stents

11.3.2.1.    Drug-eluting Stents

11.3.2.2.    Bare-metal Stents

11.3.2.3.    Bioabsorbable Stents

11.3.3.    Structural Heart Diseases

11.3.3.1.    Aortic Valve Therapy Devices

11.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

11.3.4.    Catheters

11.3.4.1.    Angiography Catheters

11.3.4.2.    Guiding Catheters

11.3.4.3.    IVUS/OCT Catheters

11.3.5.    Plaque Modification Devices

11.3.5.1.    Atherectomy Devices

11.3.5.2.    Thrombectomy Devices

11.3.6.    Hemodynamic Flow Alteration Devices

11.3.6.1.    Embolic Protection Devices

11.3.6.2.    Chronic Total Occlusion Devices

11.3.7.    Other Devices

11.3.7.1.    Guidewires

11.3.7.2.    Vascular Closure Devices

11.3.7.3.    Introducer Sheaths

11.3.7.4.    Hemostasis Valves

11.3.7.5.    Balloon Inflation Devices

11.4.    Middle East Interventional Cardiology Devices Market Attractiveness Index

11.4.1.    By Country

11.4.2.    By Product

12.    Africa Interventional Cardiology Devices Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    South Africa Countries Interventional Cardiology Devices Market

12.2.2.    Egypt Interventional Cardiology Devices Market

12.2.3.    North Africa Interventional Cardiology Devices Market

12.2.4.    Rest of Africa Interventional Cardiology Devices Market

12.3.    Africa Interventional Cardiology Devices Market, By Product

12.3.1.    Angioplasty Balloons

12.3.1.1.    Old/Normal Balloons

12.3.1.2.    Drug-eluting Balloons

12.3.1.3.    Cutting and Scoring Balloons

12.3.2.    Angioplasty Stents

12.3.2.1.    Drug-eluting Stents

12.3.2.2.    Bare-metal Stents

12.3.2.3.    Bioabsorbable Stents

12.3.3.    Structural Heart Diseases

12.3.3.1.    Aortic Valve Therapy Devices

12.3.3.2.    Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)

12.3.4.    Catheters

12.3.4.1.    Angiography Catheters

12.3.4.2.    Guiding Catheters

12.3.4.3.    IVUS/OCT Catheters

12.3.5.    Plaque Modification Devices

12.3.5.1.    Atherectomy Devices

12.3.5.2.    Thrombectomy Devices

12.3.6.    Hemodynamic Flow Alteration Devices

12.3.6.1.    Embolic Protection Devices

12.3.6.2.    Chronic Total Occlusion Devices

12.3.7.    Other Devices

12.3.7.1.    Guidewires

12.3.7.2.    Vascular Closure Devices

12.3.7.3.    Introducer Sheaths

12.3.7.4.    Hemostasis Valves

12.3.7.5.    Balloon Inflation Devices

12.4.    Africa Interventional Cardiology Devices Market Attractiveness Index

12.4.1.    By Country

12.4.2.    By Product

13.    Competitive Landscape

13.1.    Company Profiles

13.1.1.    Medtronic

13.1.1.1.    Company Overview

13.1.1.2.    Financial Overview

13.1.1.3.    Key Developments

13.1.1.4.    Strategies

13.1.1.5.    Product Analysis

13.1.2.    Boston Scientific Corporation

13.1.3.    Abbott

13.1.4.    Edward Lifesciences Corporation

13.1.5.    Cardinal Health

13.1.6.    iVascular

13.1.7.    Becton

13.1.8.    Dickinson, and Company

13.1.9.    B. Braun Melsungen

13.1.10.    Terumo Corporation

13.1.11.    Biosensors International Group

13.1.12.    BIOTRONIK SE & Co. KG

14.    Acronyms